Developments and Trends in Influenza Therapeutics (Technical Insights)

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Influenza is a burgeoning problem across the entire globe, there is an increased need for new therapeutic methods. A whole host of technology platforms are being utilized to create non egg based vaccines. The world has not seen an influenza pandemic, and in terms of historical occurrences, we are several years overdue of one. There is a critical need for a universal vaccine, that has the potential to prevent multiple strains of influenza, so that yearly vaccinations can be eliminated and healthcare costs can be reduced. The main focus of the research service features the influenza vaccine market and the types of emerging technologies as well as developing partnerships over 2010-2013.

Table of Contents

Developments and Trends in Influenza Therapeutics (Technical Insights), Developments and Trends in Influenza TherapeuticsDevelopments and Trends in Influenza TherapeuticsDevelopments and Trends in Influenza Therapeutics




Related Research

Release Date : 13-Oct-17

Region : Global

Release Date : 13-Oct-17

Region : Global

Release Date : 11-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.